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Background:  Cytokines  play  an  important  role  in controlling  the  homeostasis  of the  immune  system  in
HIV infection.  The  measurement  cytokines  in patients  with  HIV may  provide  additional  information  to
complement  prognostic  markers  and  understand  disease  procession.  Aim  of the  study  was to  determine
IL-4,  IL-10  and  TNF-˛  proﬁles  in plasma  of  HIV-infected  individuals  with  different  CD4  T-cell  levels.
Methods:  Quantitative  level  detection  of  IL-4,  IL-10,  TNF-˛  was  carried  out  by ELISA  (test  systems  “Vektor-
Best”,  RF)  in  78  HIV-infected  people  (group  I:  35  persons  with  level  of  T-helpers  ≥350  cells/L;  group  II:
43  persons  with  level  of  T-helpers  ≤200  cells/L).
Results:  HIV-infection  was  associated  with  an  increase  in plasma  levels  of  TNF-˛  and  IL-10.  Immune
imbalance  due  to  changes  in concentrations  of  cytokines  is more  pronounced  in  HIV-infected  individuals
with  severe  immunosuppression  with  CD4  T  lymphocyte  counts  ≤200  cells/L.  No  signiﬁcant  difference
in IL-4  between  surveyed  troops  and  comparison  group  was  found.
Conclusion:  Immunological  status  of  the patients  with  HIV is  characterized  by inefﬁciency  of  cellular
compartment  with  imbalance  of relation  of  immunocompetent  cells  and  increased  production  of  proin-
ﬂammatory  TNF-˛  and anti-inﬂammatory  IL-10.
© 2013 Polish AIDS Research Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
Nowadays human immunodeﬁciency virus causes a pandemic,
in consequence of which increase of HIV infection is a signiﬁcant
medical and social problem [1]. However, numerous researches,
devoted to study of pathogenesis mechanisms of illness and pecu-
liarities of disease course, don’t ﬁnd unambiguous solution.
One of the factors inﬂuencing virus replication in body is
cytokines some of them are able to favour HIV replication increas-
ing expression of regulatory agent genes [2]. Many authors indicate
that imbalance of interleukins produced by T-helpers of the 1st
and 2nd type form the basis of immune system response to virus
antigens. Thus, by progression of disease T1 helper response is sup-
pressed that leads to disorder of stimulation of cellular component.
At the same time, there is an increase of levels of anti-inﬂammatory
cytokines, which in their turn cause relatively inefﬁcient antibody
resistance [3–5].
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TNF-  ˛ plays a crucial role in viral genome expression by HIV
infection. Increase of serum concentration of TNF-  ˛ by illness pro-
gression is noted by many researchers, the majority of which
underline correlation of the following increase with quantity reduc-
tion of CD4+ lymphocytes and severity of clinical characteristics of
disease [6–8]. Signiﬁcance of IL-10 in course of disease consists in
its ability both decrease and increase viral replication depending
on presence of other cytokines. High levels of IL-10 are recorded in
serum of infected people at late stages of the disease [9,10]. More
controversial data about the role of IL-4 are: despite of separate
notes about decrease of cytokine level many researches state about
increase of its concentration by infection progression [2,11,12].
Therefore, cytokine balance plays an important role in regula-
tion of homeostasis of immune system and inﬂuences the course
of HIV infection and the research of cytokine status changes in
HIV-infected people will allow to understand better a disease
pathogenesis and will give additional information about mecha-
nism of disease course.
Aim of study
The aim of this research was to study changes of cytokine proﬁle
in HIV-infected people by indexes of IL-4, IL-10 and TNF-  ˛ content
and the peculiarities of disease course depending on cell-mediated
immunity.
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Table 1
Social and demographic characteristics in patients with HIV infection.
Index Group I (n = 35) Group II (n = 43)
Average age, years 31.2 ± 0.86 34.5 ± 1.70
Male, abs./% 23/(65.71 ± 8.14)% 30/(69.77 ± 7.09)%
Parenteral way  of
transmission, abs./%
25/(71.43 ± 7.85)% 27/(62.79 ± 7.46)%
Sexual way  of
transmission, abs./%
10/(28.57 ± 7.55)% 16/(37.21 ± 7.46)%
HAART, abs./% 11/(31.43 ± 7.96)% 12/(27.91 ± 6.92)%
Experience of HIV
infection, years
3.69 ± 0.31 1.90 ± 0.62a
a Signiﬁcant difference of index compared to group I, p < 0.05.
Materials and methods
78 HIV-infected people were under supervision, among which
there were 53 (67.9%) men  and 25 (32.1%) women at the age
of (32.61 ± 0.87), who were under hospital treatment in Sumy
Regional Clinical Infectious Diseases Hospital named after Z.I.
Krasovytskyi (SOKIL), Sumy, Ukraine. The patients were divided
into groups depending on level of CD4+ T-lymphocytes. 35 people
with level of T-helpers ≥350 cells/L fell under group I, 43 people
with level of T-helpers ≤200 cells/L – under group II. Comparable
by sex and age 30 clinically healthy blood donors made experimen-
tal group.
Quantitative level detection of IL-4, IL-10, TNF-  ˛ was carried out
by ELISA (test systems “Vektor-Best”, RF) in blood serum accord-
ing to the instructions of manufacturing plant on the basis of SOKIL
Clinical Diagnostic Laboratory. Parameters of cellular compartment
of immune system (quantity of CD3+ lymphocytes, quantity of
CD4+ subpopulation of T-helpers, quantity of CD8+ subpopulation
of T-suppressors in 1 L of blood, ratio index of CD4+/CD8+ lym-
phocyte subpopulation) are received on the basis of immunologic
laboratory of Regional Centre for Prophylaxis and Fight against HIV
infection/AIDS. Moreover, generally accepted and provided by the
protocol examinations were carried out. Persons were included into
the research only by their written consent.
Results
While studying social and demographic data it was  found out
that HIV-infected people of investigated groups didn’t differ by gen-
der, age characteristics and mode of virus infection (Table 1). The
fact, that less illness experience was deﬁnitely recorded among the
patients of group II, draws attention. Thus, in persons with level of
CD4+ T-lymphocytes ≤200 cells/L the average number of years,
which passed after establishment of HIV infection diagnosis to the
moment of hospitalization, was 2 times less than in persons from
group I (p < 0.01).
By structural division of groups according to reason HIV1/2 anti-
body test (Fig. 1) no reliable differences by patient examination
were found: as injecting drug users (code 102); people with sexu-
ally transmitted diseases (code 104); people with multiple sexual
partners, including men, who have sex with other men  (code 105);
people who has been deprived of their liberty (code 112); pregnant
women (code 109). However, deﬁnitely greater number of patients
who were screened for clinical indications (code 113) was regis-
tered in group II that together with little infection experience can
indicate late illness diagnosis in this contingent already at the stage
of clinical indications.
Comparison of HIV infection clinical stages (World Health Orga-
nization, 2006) of patients of studied groups allowed to discover
(Fig. 2) that only in persons with level of T-helpers ≥350 cells/L
stage of carrier without symptoms was noted and III clinical stage
was met  2.2 times more often (p < 0.05). In group II patients with
Fig. 1. Groups structure depending on the cause of testing for HIV. *signiﬁcant
difference of index compared to group I, p < 0.05.
Fig. 2. Groups structure depending on clinical stage of HIV infection. *signiﬁcant
difference of index compared to group I, p < 0.05.
ﬁnal stage of disease dominated (index 3.2 times exceeded the
similar one among persons of group I, p < 0.05).
At the moment of health encounter general state of patients of
group I was  estimated as of medium severity in 82.9%, that is 1.7
times more than among the representatives of group II (p < 0.05). In
patients with level of immunocompetent cells ≤200 cells/L severe
condition was  recorded in 30.2% of cases, extremely severe condi-
tion – in 18.6%, that 3.5 times exceeds the corresponding indexes
of group I and 18.6 relatively (p < 0.05).
Study of pathology structure associated with HIV indicated the
fact that the most widespread were the infections, caused by Can-
dida fungus and B and C hepatitis viruses (Fig. 3). Only in cohort of
persons with level of CD4+ T-lymphocytes ≤200 cells/L extrapul-
monary tuberculosis, cachexia were diagnosed; organic lesion of
central nervous system was met  deﬁnitely more often (2.5 times).
Fig. 3. Clinical manifestations in patients with HIV infection. *signiﬁcant difference
of  index compared to group I, p < 0.05.
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Table 2
Cell immunity indices in patients with HIV infection.
Index Blood donors (n = 30) Group I (n = 35) Group II (n = 43)
CD4+, cells/L 992.47 ± 29.53 446.35 ± 20.07a 115.21 ± 11.72a,b
CD3+, cells/L 1330.77 ± 54.39 1483.08 ± 38.40a 835.79 ± 100.65a,b
CD8+, cells/L 828.17 ± 16.01 1042.85 ± 32.01a 602.91 ± 95.72a,b
CD4+/CD8+ 1.21 ± 0.04 0.43 ± 0.01a 0.23 ± 0.03a,b
a Signiﬁcant difference of index compared to blood donors, p < 0.001.
b Signiﬁcant difference of index compared to group I, p < 0.001.
In patients the index of opportunistic infections (number of
infections diagnosed with a patient) ranged from 1 to 5. In patients
with severe immunodeﬁciency this index was higher – (3.21 ± 0.22)
in group II vs. (1.65 ± 0.32) in I (p < 0.05).
As it could be seen from the Table 2 in HIV-infected patients by
the research of indexes of cellular compartment of immunity sig-
niﬁcantly decreased indexes of CD4+ T-lymphocytes were recorded
in comparison to healthy persons (group I – 2.2; II – 8.6) and ratio
decrease of CD4+/CD8+ (group I – 2.8; II – 5.3 times). Average val-
ues of pool of CD3+, CD8+ lymphocytes in patients with level of
T-helpers ≥350 cells/L deﬁnitely exceeded the values of persons
from experimental group and group II. Changes in immune sta-
tus of patients of group II were more expressed that is proved by
presence of deﬁnite difference of indexes with patient cohort of
group I (p < 0.05).
As it is showed in Fig. 4 there was  increase of level
of proinﬂammatory cytokine TNF-  ˛ in comparison to control
(group I – (0.77 ± 0.08), II – (2.34 ± 0.69), experimental group –
(0.51 ± 0.32) pg/ml, p < 0.05) and anti-inﬂammatory IL-10 (group I  –
(3.99 ± 0.99), II – (20.08 ± 4.44), experimental group – (1.68 ± 0.32)
pg/ml, p < 0.001) in cytokine proﬁle of all HIV-infected. No deﬁ-
nitely signiﬁcant difference in IL-4 production was found out among
examined population.
Signiﬁcant increase of TNF-  ˛ and IL-10 was noted in patients
with level of CD4+ T-lymphocytes ≤200 cells/L in comparison to
persons of group I (p < 0.05) that causes the presence of deep imbal-
ance of immune response at late stages of the disease. Among
HIV-infected of group II average level of serum concentration
of TNF-  ˛ 3 times exceeded the corresponding index of group I
(p < 0.05). Great increase of cytokine concentration was  noted in
persons with severe immunodeﬁciency by comparison of IL-10 val-
ues (IL-10 level in group II turned out to be 5 times higher p < 0.05),
that can mediately indicate about more active involvement of IL-10
in processes of illness progression. Power of correlative relation-
ships in patients of group II between concentration of this cytokine
and index of opportunistic infections in comparison to similar
Fig. 4. IL-4, IL-10 and TNF-  ˛ serum concentration indices in studied groups.
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Fig. 5. Cell immunity and cytokine proﬁle indices correlation in studied groups.
*reliability correlation, p < 0.05.
values TNF-  ˛ (IL-10: r = 0.23, p < 0.05; TNF-˛: r = 0.17, p < 0.05) also
speaks in favour of this assumption; with severity of patient’s gen-
eral state (IL-10: r = 0.43, p < 0.05; TNF-˛: r = 0.25, p < 0.05).
By research of correlative relationships in groups of HIV-
infected patients feedback of various power between quantity of
CD4 cells, ratio of CD4+/CD8+ lymphocytes and IL-10 and TNF-˛
levels was discovered (Fig. 5).
It is necessary to note that in persons with highly expressed
immunodeﬁciency level dependence of immunocompetent cells
and serum concentration of cytokines is more signiﬁcant. Thus, in
group with level of T-helpers ≥350 cells/L, correlative relation-
ship was inverse weak (IL-10: r = −0.28, p < 0.05; TNF-˛: r = −0.18,
p < 0.05), among the people with level of CD4-lymphocytes
≤200 cells/L inverse relationship of medium power was recorded
(IL-10: r = −0.47, p < 0.05; TNF-˛: r = −0.42, p < 0.05).
Discussion
Changes of lymphocyte subpopulation in HIV-infected people
were discovered that are characterized by change of number of
immunocompetent cells with CD+ phenotype and their ratio, prove
modern concept of global immune imbalance by progression of
disease [4,6,13]. The obtained results coincide with the data of
foreign researches – cytokine balance plays a signiﬁcant role in HIV-
associated immune disfunction, when both anti-inﬂammatory and
proinﬂammatory cytokine links activate, with high concentration
of IL-10 and TNF-  ˛ [6,8–10]. Association of high level of circulating
TNF-˛ with unfavourable course of infection [2,4] was  also proved.
It is suggested that IL-10 has negative consequences by HIV infec-
tion because of ability to inﬂuence directly on viral replication in
T-helpers, monocytes and dendritic cells [9]; to modulate differen-
tially cellular apoptosis of pool of CD4+ and CD8+ lymphocytes [14];
also IL-10 can renew blockade of T-cellular proliferative response in
patients with relatively saved number of T-helpers but this ability
is being lost during progression of illness [15].
Conclusions
1. Among the examined HIV-infected with number of CD4+ lym-
phocytes ≤200 cells/L late stages of disease, severe course of
disease, pulmonary and extrapulmonary tuberculosis, organic
lesions of nervous system, cachexia, higher index of opportunis-
tic infections were deﬁnitely registered more often.
2. Immune status of HIV-infected persons is characterized by deﬁ-
ciency of cell component of immune system and changes in
cytokine status with increased production of proinﬂammatory
TNF-  ˛ and anti-inﬂammatory IL-10.
3. Immune imbalance that is caused by changes of cell component
and cytokine level is more expressed in HIV-infected persons
with level of CD4+ lymphocytes ≤200 cells/L.
4. Cytokine proﬁle interacts with level of immunocompetent cells
that is proved by presence of correlative relationships between
serum concentration of IL-10, TNF-  ˛ and T-helpers.
5. Evident changes of IL-10 level in patients at late stages of illness
and correlative relationships with index of opportunistic infec-
tions and severity of general state indicate active involving of
this cytokine in immunopathogenesis of HIV infection.
Therefore, the notions of levels of IL-10 and TNF-  ˛ cytokines can
be considered as additional prognostic markers of HIV infection
progression and the conducted immunological researches point out
the necessity of further study of cytokine chain for the purpose of
determination of pathogenic relationships of cell cooperation by
deteriorative course of disease and potential of use of interleukins
for therapeutic purposes.
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